The rhodium-catalysed enantioselective 1,4-addition of 5 organoboron reagents to arylidene Meldrum's acids as acceptors, allows convenient access to 4-arylchroman-2-ones with good to excellent levels of enantioselectivity. The use of silyl-protected dioxaborinanes as donors was found to be advantageous to achieving good yields of product under
anhydrous conditions.
The enantioselective construction of C-C bonds using the rhodium-catalysed 1,4-addition of organometallics is established as an important tool for organic synthesis. 1 For the addition of aryl and alkenylboronic acids, the reaction is routinely carried out 15 in aqueous solvents and can afford excellent enantioselectivities across a wide-range of alkene acceptors. In the majority of applications, boronic acids are the coupling partners of choice for conjugate addition reactions. However, there can be issues with purification and manipulation. Often, an excess of reagent has to 20 be used due to competing protodeboronation processes and by competing formation of trimeric cyclic anhydrides (boroxines) in solution, leading to difficulties in being able to accurately measure reaction stoichiometry. 2 Pleasingly, the cyclic triolborate 5 and the silyl-protected dioxaborinane 7 gave the desired product 2 with no traces of decomposition products. The superior conversions and good isolated yield obtained with 7 prompted further investigation of this novel organoboron reagent. The silyl-protected 60 dioxaborinanes are readily prepared in high yield by heating an arylboronic acid with 2-(hydroxymethyl)-2-methylpropane-1,3-diol under Dean-Stark conditions followed by treatment with chlorotrimethylsilane in the presence of triethylamine (See Supporting Information for full details). The arylboron products 65 are easily purified by flash chromatography and can be stored on the bench for several months with no evidence of decomposition. With a range of silyl-protected dioxaborinane reagents in hand, the scope of the rhodium-catalysed addition to arylidene Meldrum's acid acceptors was explored (Scheme 2).
70
Employing the optimised set of reaction conditions, the isolated yields were consistently good for arylidene Meldrum's acid acceptors that possessed electron-donating ether substituents (Scheme 2, 9-16). In contrast, arylidene Meldrum's acid derivative 8 with the para-F group on the aryl ring was unreactive under the standard reaction conditions. Similarly, other electron-withdrawing substituents (Br and NO 2 ) were not tolerated on the acceptor.
10 This observation can be rationalised by the inductive deactivation of the hindered trisubstituted alkene derivative to carbometallation. Substitution of the silyl-protected dioxaborinane was possible at the ortho, meta, and para positions. However, yields were compromised when both donor 15 and acceptor were ortho-substituted (Scheme 2, 11-13). With the optimised set of reaction conditions, we next established that silyl-protected dioxaborinane 7 could be employed for the addition to typical cyclic activated alkenes (Scheme 3). 13 However, coumarins tend to be relative poor substrates for conjugate additions, thus up to ten equivalents of boronic acid donor were required for successful conversion to product. Our alternative strategy shown in Figure 1 is based on an 35 enantioselective rhodium-catalysed 1,4-addition to (2-benzyloxy)phenyl arylidene Meldrum's acid derivative followed by hydrolysis/decarboxylation of the cyclic malonate, deprotection of the benzyl ether and intramolecular esterification to provide the desired 4-arylchroman-2-one products. The development of an enantioselective rhodium-catalysed 1,4-addition to (2-benzyloxy)phenyl alkylidene Meldrum's acid derivative proved to be challenging. Preliminary attempts using a [Rh(C 2 H 4 ) 2 Cl] 2 precatalyst in the presence of atropisomeric bidentate phosphine ligands afforded no desired product, both the silyl-protected dioxaborinane donor and the alkene were recovered intact. Enantiopure diene ligands can substitute for chiral phosphines in 10 enantioselective processes and often show superior reactivity and enantioselectivity. 14 Fortunately, the enantiopure diene (R,R)-Phbod* introduced by Hayashi and co-workers allowed the arylation to proceed with good reactivity and enantioselectivity under anhydrous conditions (Scheme 4). 15 The isolated yields obtained 15 with the enantiopure diene ligand (R,R)-Ph-bod* were consistent with the racemic protocol. Substitution of the silyl-protected dioxaborinane at the para position afforded excellent yields of product (Scheme 4, 11, 14 and 15) with lower yields for the meta substituted aryl group in 12 and poor yields for the ortho,ortho 20 substituted product 13. The enantioselectivity was determined after conversion to the 4-arylchroman-2-one products 16-21. Thus, the enantioenriched Meldrum's acid derivative 10-15 was heated in a stirring mixture of DMF and aqueous HCl to afford the carboxylic acid. Hydrogenation of the crude reaction mixture 25 in ethyl acetate in the presence of palladium impregnated on carbon led to deprotection of the benzyl ether. The resulting phenol was then heated in the presence of a catalytic amount of para-toluenesulfonic acid to afford the desired product 16-21 over three steps (Scheme 5). The enantioselectivity was good for 30 a range of silyl-protected dioxaborinane donors (up to 97% ee for 20). The enantioselectivity was significantly lower when both donor and acceptor were ortho-substituted (Scheme 5, 9). The absolute configuration of 20 was determined to be (R)-by X-ray crystallography ( Figure 2) . A recent density functional theory 35 study of the rhodium-catalysed addition of phenylboronic acid to cyclohexenone offers useful insight into the origin of enantioselectivity with Rh(I)/Ph-bod* complexes.
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Conclusions
In conclusion, we have shown that silyl-protected dioxaborinanes 40 perform exceptionally well as donors in rhodium-catalysed 1,4-addition reactions under anhydrous conditions. In the scenario presented here, this allowed an enantioselective addition to arylidene Meldrum's acid derivatives and a subsequent asymmetric synthesis of 4-arylchroman-2-ones. Further studies to 45 explore the application of these new donors in additions to other challenging alkene acceptors and to explain their unique properties is in progress. 
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